NDAOPHTHALMICSUSPENSION/DROPS
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
FML FORTE (fluorometholone) by AbbVie is corticosteroid hormone receptor agonists [moa]. First approved in 1986.
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FML FORTE is a topical ophthalmic corticosteroid suspension containing fluorometholone, a corticosteroid hormone receptor agonist. It is used to treat inflammatory and allergic eye conditions by suppressing ocular inflammation and immune responses. The drug works by binding to corticosteroid receptors to reduce conjunctival, corneal, and anterior chamber inflammation.
$0.887MPart D
LOE ApproachingThis mature product approaching loss of exclusivity operates in a stable but declining market with moderate competitive pressure, suggesting smaller brand teams focused on defensive positioning rather than growth.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FML FORTE offers exposure to mature product management and defensive commercial strategy in ophthalmology, a stable therapeutic area with established clinical protocols. This role suits professionals seeking to build foundational commercial skills or transition toward lifecycle management expertise in preparation for LOE planning.
Brand Manager
Worked on FML FORTE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.